Equities

Oncimmune Holdings PLC

ONC:LSE

Oncimmune Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)11.20
  • Today's Change0.05 / 0.45%
  • Shares traded16.64k
  • 1 Year change-27.51%
  • Beta0.7070
Data delayed at least 20 minutes, as of Jun 28 2024 16:08 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Aug 31 2023202320222021
ASSETS
Cash And Short Term Investments3.211.438.63
Total Receivables, Net2.121.676.85
Total Inventory0.240.430.14
Prepaid expenses--0.080.43
Other current assets, total------
Total current assets5.573.6116
Property, plant & equipment, net0.591.341.59
Goodwill, net1.581.581.58
Intangibles, net0.483.024.12
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets8.441024
LIABILITIES
Accounts payable--0.450.77
Accrued expenses00.691.21
Notes payable/short-term debt--00
Current portion long-term debt/capital leases0.336.432.56
Other current liabilities, total0.200.265.23
Total current liabilities1.427.829.77
Total long term debt4.974.216.91
Total debt5.30119.47
Deferred income tax0.100.310.37
Minority interest------
Other liabilities, total1.282.002.00
Total liabilities7.781419
SHAREHOLDERS EQUITY
Common stock0.740.700.69
Additional paid-in capital434140
Retained earnings (accumulated deficit)(43)(44)(34)
Treasury stock - common0(1.93)(1.93)
Unrealized gain (loss)------
Other equity, total(0.22)(0.04)0.09
Total equity0.66(4.18)5.23
Total liabilities & shareholders' equity8.441024
Total common shares outstanding746969
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.